208 related articles for article (PubMed ID: 20536098)
1. [Imiquimod cream. A cream to use with precaution].
Taeron C
Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
[No Abstract] [Full Text] [Related]
2. Beyond a decade of 5% imiquimod topical therapy.
A Gaspari A; Tyring SK; Rosen T
J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
4. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
Akkilic-Materna M; Massone C; Komericki P
Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
[TBL] [Abstract][Full Text] [Related]
6. [Photodynamic therapy vs imiquimod].
Serra-Guillén C; Nagore E; Guillén C
Actas Dermosifiliogr; 2012; 103(6):488-501. PubMed ID: 22178262
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.
Wagstaff AJ; Perry CM
Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
Knackstedt TJ; Quitadamo M
Cutis; 2015 Feb; 95(2):E20-3. PubMed ID: 25750973
[TBL] [Abstract][Full Text] [Related]
9. The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions.
Cannon PS; O'Donnell B; Huilgol SC; Selva D
Br J Ophthalmol; 2011 Dec; 95(12):1682-5. PubMed ID: 20702431
[TBL] [Abstract][Full Text] [Related]
10. Treating skin cancer with topical cream.
Micali G; Lacarrubba F; Dinotta F; Massimino D; Nasca MR
Expert Opin Pharmacother; 2010 Jun; 11(9):1515-27. PubMed ID: 20408746
[TBL] [Abstract][Full Text] [Related]
11. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
[No Abstract] [Full Text] [Related]
12. Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients.
Waalboer-Spuij R; Holterhues C; van Hattem S; Schuttelaar ML; Gaastra MT; Kuijpers DI; Hollestein LM; Nijsten TE
Dermatology; 2015; 231(1):56-62. PubMed ID: 25925162
[TBL] [Abstract][Full Text] [Related]
13. Topical treatment of basal cell carcinoma with the immune response modifier imiquimod.
Papakostas D; Stockfleth E
Future Oncol; 2015 Nov; 11(22):2985-90. PubMed ID: 26450707
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
Navi D; Huntley A
Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486
[TBL] [Abstract][Full Text] [Related]
15. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
Shulstad RM
Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
[TBL] [Abstract][Full Text] [Related]
16. The use of imiquimod in the treatment of periocular tumours.
Ross AH; Kennedy CT; Collins C; Harrad RA
Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic options for actinic keratosis and basal cell carcinoma.
Sligh JE
Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S76-80. PubMed ID: 25268601
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation and efficacy of Imiquimod 3.75% cream for the treatment of actinic keratosis, pigmented basal cell carcinomas, and actinic cheilitis.
Paolino G; Cantoresi F; Mercuri SR; Cantisani C
Dermatol Ther; 2020 May; 33(3):e13356. PubMed ID: 32239714
[No Abstract] [Full Text] [Related]
19. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
[No Abstract] [Full Text] [Related]
20. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
[No Abstract] [Full Text] [Related]
[Next] [New Search]
